Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemotherapy

Mathematical Biosciences

Volumn 206, Issue 2, 2007, Pages 320-342

  Ledzewicz, Urszula ^a   Schättler, Heinz ^b  

^a SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE   (United States)

^b WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; CHEMOTHERAPY; COMPUTER SIMULATION; MATHEMATICAL MODELS; PHARMACOKINETICS; TISSUE;

BONE MARROW; CANCER CHEMOTHERAPY; PHARMACOKINETIC EQUATIONS;

OPTIMAL CONTROL SYSTEMS;

BONE; CANCER; CHEMOTHERAPY; CONCENTRATION (COMPOSITION); NUMERICAL MODEL;

ARTICLE; BONE MARROW DEPRESSION; CANCER CHEMOTHERAPY; DISEASE MODEL; DISEASE SIMULATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; MATHEMATICAL MODEL; MEDICAL ILLUSTRATION;

ALGORITHMS; ANTINEOPLASTIC AGENTS; BONE MARROW; BONE MARROW CELLS; CELL PROLIFERATION; COMPUTER SIMULATION; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS;

EID: 33947585997     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mbs.2005.03.013     Document Type: Article

References (29)

1. Afenya E.K. Recovery of normal hemopoiesis in disseminated cancer therapy - a model. Math. Biosci. 172 (2001) 15
2. Agur Z. The effect of drug schedule on responsiveness to chemotherapy. Ann. New York Acad. Sci. 504 (1986) 274
3. Agur Z., Arnon R., and Schechter B. Reduction of cytotoxicity to normal tissues by new regimes of cell-cycle phase-specific drugs. Math. Biosci. 92 (1988) 1
4. Cojocaru L., and Agur Z. A theoretical analysis of interval drug dosing for cell-cycle-phase-specific drugs. Math. Biosci. 109 (1992) 85
5. Bryson A.E., and Ho Y.C. Applied Optimal Control (1975), Hemisphere
6. Dibrov B.F., Zhabotinsky A.M., Neyfakh Yu.A., Orlova M.P., and Churikova L.I. Mathematical model of cancer chemotherapy. Periodic schedules of phase-specific cytotoxic-agent administration increasing the selectivity of therapy. Math. Biosci. 73 (1985) 1
7. Duda Z. A gradient method for application of chemotherapy protocols. J. Biol. Syst. 3 (1995) 3
8. Eisen M. Mathematical Models in Cell Biology and Cancer Chemotherapy. Lecture Notes in Biomathematics vol. 30 (1979), Springer
9. Fister K.R., and Panetta J.C. Optimal control applied to cell-cycle-specific cancer chemotherapy. SIAM J. Appl. Math. 60 (2000) 1059
10. Hainsworth J.D., and Greco F.A. Paclitaxel administered by 1-hour infusion. Cancer 74 (1994) 1377
11. Hill B.T. Cancer chemotherapy. The relevance of certain concepts of cell cycle kinetics. BBB (Rev. Canc. 516 (1978) 389
12. Krener A. The high-order maximal principle and its application to singular controls. SIAM J. Contr. Optim. 15 (1977) 256
13. Ledzewicz U., and Schättler H. Optimal bang-bang controls for a 2-compartment model in cancer chemotherapy. J. Optim. Theory Appl. - JOTA 114 (2002) 609
14. Ledzewicz U., and Schättler H. Analysis of a cell-cycle specific model for cancer chemotherapy. J. Biol. Syst. 10 (2002) 183
15. Ledzewicz U., and Schättler H. Controlling a model for bone marrow dynamics in cancer chemotherapy. Math. Biosci. Eng. 1 (2004) 95
16. Ledzewicz U., and Schättler H. The influence of PK/PD on the structure of optimal controls in cancer chemotherapy models. Math. Biosci. Eng. 2 3 (2005) 561
17. Lopes M.M., Adams E.G., Pitts T.W., and Bhuyan B.K. Cell kill kinetics and cell cycle effects of Taxol on human and hamster ovarian cell lines. Cancer Chemother. Pharmacol. 32 (1993) 235
18. Martin R.B. Optimal control drug scheduling of cancer chemotherapy. Automatica 28 (1992) 1113
19. Mohler R.R. Bilinear Control Systems (1973), Academic Press
20. Murray J.M. Optimal drug regimens in cancer chemotherapy for single drugs that block progression through the cell cycle. Math. Biosci. 123 (1994) 183
21. Noble J., and Schättler H. Sufficient conditions for relative minima of broken extremals in optimal control theory. J. Math. Anal. Appl. 269 (2002) 98
22. Panetta J.C. A mathematical model of breast and ovarian cancer treated with paclitaxel. Math. Biosci. 146 (1997) 83
23. Pontryagin L.S., Boltyanskii V.G., Gamkrelidze R.V., and Mishchenko E.F. The Mathematical Theory of Optimal Processes (1964), MacMillan, New York
24. Swan G.W. Role of optimal control in cancer chemotherapy. Math. Biosci. 101 (1990) 237
25. Swierniak A., Ledzewicz U., and Schättler H. Optimal control for a class of compartmental models in cancer chemotherapy. Int. J. Appl. Math. Comput. Sci. 13 (2003) 101
26. Swierniak A., Polanski A., and Kimmel M. Optimal control problems arising in cell-cycle-specific cancer chemotherapy. Cell Proliferat. 29 (1996) 117
27. Ten Bokkel Huinink W.W., Eisenhauser E., and Swenerton K. Preliminary evaluation of a multicenter randomized study of TAXOL (paclitaxel) dose and infusion length in platinum-treated ovarian cancer. Cancer Treatment Rev. 19 (1983) 79
28. Webb G.F. Resonance phenomena in cell population chemotherapy models. Rocky Mountain J. Math. 20 (1990) 1195
29. Webb G.F. Resonance in periodic chemotherapy scheduling. In: Lakshmikantham V. (Ed). Proceedings of the First World Congress of Nonlinear Analysts vol. 4 (1995), Walter DeGruyter, Berlin 3463